Skip to content

Opening book details…

About this Medicine article

396 MGCD265, an orally active Met/VEGFR multitargeted kinase inhibitor, in combination with docetaxel: clinical and preclinical experience by P. O'Dwyer; K. Papadopoulos; R. Amaravadi; K. Harlacker; M. Beeram; M. Drouin; M. Mehran; J. Besterman; C. Maroun; A. Patnaik is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
P. O'Dwyer; K. Papadopoulos; R. Amaravadi; K. Harlacker; M. Beeram; M. Drouin; M. Mehran; J. Besterman; C. Maroun; A. Patnaik
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
Published
2010
Language
EN
Field
Medicine (Health Sciences)

More by P. O'Dwyer; K. Papadopoulos; R. Amaravadi; K. Harlacker; M. Beeram; M. Drouin; M. Mehran; J. Besterman; C. Maroun; A. Patnaik

Browse all works by P. O'Dwyer; K. Papadopoulos; R. Amaravadi; K. Harlacker; M. Beeram; M. Drouin; M. Mehran; J. Besterman; C. Maroun; A. Patnaik